VarSome is sponsoring this year'sAmerican Society of Human Genetics Virtual Annual Meeting, October 18-22.

Saphetor was featured in a Forbes article this week, highlighting the companies doing great work in the UK genomics ecosystem. The article covers our founder and CEO, Andreas Massouras, VarSome, and the incredible growth of the company through smart...

VarSome is sponsoring this year's European Human Genetics Conference, hosted by the European Society of Human Genetics, August 28-31.

Lausanne, Switzerland - March 11, 2021 - Saphetor SA, a Swiss-based precision medicine company specializing in analysis and interpretation of genomic data, announced today a distribution agreement with BioCat GmbH, a leading provider of innovative...

Lausanne, Switzerland - February 25, 2021 - Saphetor SA, a Switzerland-based precision medicine company using bioinformatics to apply human genome data to benefit people, announced today a distribution agreement with Annar Health Technologies...

As part of the #ASHG2020 event, we’re hosting a CoLab “VarSome’s implementation of ACMG guidelines” Register to hear how VarSome is automating ACMG guidelines within VarSome Clinical:

Lausanne, Switzerland - July 22, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with ELTA 90...

Lausanne, Switzerland - July 10, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Decode...

Lausanne, Switzerland - May 19, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with TATAA...

Lausanne, Switzerland - May 18, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Thunder...